Vasttherapeutics.com

Vasttherapeutics.com has Server used 199.34.228.77 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2018-05-04 (1 year, 265 days) and hosted in San Francisco United States, server ping response time 81 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Vasttherapeutics keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Vast therapeutics
2 Vast therapeutics news
3 Vast therapeutics inc
4 Vast therapeutics address
5 Vast therapeutics careers
6 Vast therapeutics durham nc
7 Vast therapeutics stock price
8 Vast therapeutics a series 15m
9 Vast therapeutics series a 2019

Hosting Provider

Website: Vasttherapeutics.com
Hostname: pages-custom-29.weebly.com
Country:
Region: CA
City: San Francisco
Postal Code: 94111
Latitude: 37.798900604248
Longitude: -122.39839935303
Area Code: 415
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Cordeepleinair.net (3 seconds ago)

   » Pewnews.org (1 seconds ago)

   » Opencorpdata.com (6 seconds ago)

   » Pcso-lotto-results.com (2 seconds ago)

   » Vasttherapeutics.com (0 seconds ago)

   » Buyonlinewwwmen.com (10 seconds ago)

   » Sl-rental.com (5 seconds ago)

   » Ntea.com (8 seconds ago)

   » Momotestkitchen.com (39 seconds ago)

   » Arcoplast.org (27 seconds ago)

Results For Websites Listing

Found 56 Websites with content related to this domain, It is result after search with search engine

Vast Therapeutics - Home

(4 day ago) Vast Therapeutics is a development-stage pharmaceutical company that develops therapies to treat resistant bacteria and enable patients suffering from severe respiratory diseases to breathe better and live life more fully.

https://www.vasttherapeutics.com/

DA: 24 PA: 24 MOZ Rank: 25

Vast Therapeutics | North Carolina Biotech Center

(1 month ago) Vast Therapeutics. Vast Therapeutics uses a nitric oxide technology for the treatment of cystic fibrosis and other respiratory diseases. www.vasttherapeutics.com. 4222 Emperor Blvd., Suite 470. Durham, NC 27703 . Phone (919) 321-1375. County . Durham. Region . Triangle. Company Details. Company type .

https://directory.ncbiotech.org/content/vast-therapeutics

DA: 23 PA: 26 MOZ Rank: 49

Vast Therapeutics Receives Qualified Infectious Disease

(17 day ago) Vast Therapeutics, a subsidiary of KNOW Bio, LLC, is an innovative, preclinical-stage pharmaceutical company focused on helping people who suffer from severe respiratory diseases to breath better and live life more fully.

https://www.biospace.com/article/releases/vast-therapeutics-receives-qualified-infectious-disease-product-status-for-bioc11/

DA: 16 PA: 50 MOZ Rank: 50

Vast Therapeutics (formerly Novoclem) Announces Results

(10 day ago) Vast Therapeutics (formerly Novoclem) Announces Results Showing Eradication of all In Vitro Tested Multi-Drug Resistant Bacteria and a 99% Reduction of Nontuberculous Mycobacteria (NTM) in Animal

https://www.prnewswire.com/news-releases/vast-therapeutics-formerly-novoclem-announces-results-showing-eradication-of-all-in-vitro-tested-multi-drug-resistant-bacteria-and-a-99-reduction-of-nontuberculous-mycobacteria-ntm-in-animal-model-300652648.html

DA: 18 PA: 50 MOZ Rank: 50

Vast Therapeutics | Crunchbase

(12 day ago) Vast Therapeutics is an innovative, preclinical-stage pharmaceutical company . Durham, North Carolina, United States. Categories Biotechnology, Pharmaceutical Headquarters Regions Research Triangle, East Coast, Southern US Founded Date 2017 Operating Status Active Funding Status Early Stage Venture Last Funding Type Series A Number of Employees

https://www.crunchbase.com/organization/vast-therapeutics

DA: 18 PA: 31 MOZ Rank: 49

VLP Therapeutics – Imagine: Vaccines Without Borders

(5 day ago) VLP Therapeutics Receives FDA Clearance of Investigational New Drug Application and Initiates First Clinical Trial of VLPM01 Malaria Vaccine. Gaithersburg, MD – VLP Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a clinical trial of the Company’s VLPM01 malaria vaccine.

https://vlptherapeutics.com/

DA: 19 PA: 19 MOZ Rank: 20

Avast Therapeutics | Advancing New Treatments for Neural

(10 day ago) Peptides that exhibit in vivo activity similar to large proteins. Screens have identified biologically active leads; Selected candidates have demonstrated an intranasal CNS distribution in rats & NHPs and target activation

https://avasttherapeutics.com/

DA: 21 PA: 21 MOZ Rank: 22

About Avast - About Us | Avast Therapeutics

(9 day ago) Avast Leadership. The founders have collectively over 100 years of experience in neuroscience. Our collective experience and expertise in all the critical areas provides the leadership needed for successfully advancing new drugs into clinical trials.

https://avasttherapeutics.com/about-us/

DA: 21 PA: 10 MOZ Rank: 31

Home - VTV Therapeutics

(10 day ago) vTv Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs.

https://vtvtherapeutics.com/

DA: 19 PA: 19 MOZ Rank: 20

Recently Analyzed Sites